Compositions and Methods Involving Transforming Extracellular Vesicles
Summary
The European Patent Office published patent EP3826603A1 granted to Mayo Foundation for Medical Education and Research. The patent covers compositions and methods involving transforming extracellular vesicles, with designated states across EU member states and other European jurisdictions.
What changed
EPO granted patent EP3826603A1 to Mayo Foundation for Medical Education and Research on March 25, 2026. The patent relates to compositions and methods involving transforming extracellular vesicles, classified under multiple IPC codes including A61K 8/11, A61K 35/16, and A61K 9/51. The designated states cover all EU member states plus Switzerland, Norway, and other European Patent Convention members.
This patent grant establishes exclusive intellectual property rights for Mayo Foundation in the specified jurisdictions. Competitors developing similar extracellular vesicle technologies should review potential infringement implications. Healthcare and pharmaceutical companies utilizing extracellular vesicle compositions should conduct freedom-to-operate analyses to assess licensing requirements.
What to do next
- Review patent claims for potential overlap with existing or planned products involving extracellular vesicles
- Conduct freedom-to-operate analysis if developing similar technologies
- Consider licensing negotiations with Mayo Foundation if relevant compositions are within patent scope
Source document (simplified)
COMPOSITIONS AND METHODS INVOLVING TRANSFORMING EXTRACELLULAR VESICLES
Publication EP3826603A1 Kind: A1 Mar 25, 2026
Applicants
Mayo Foundation for Medical Education and Research
Inventors
SABBAH, Michael, BEHFAR, Atta, LIVIA, Christopher, PETERSON, Timothy
IPC Classifications
A61K 8/11 20060101AFI20220401BHEP A61K 8/14 20060101ALI20220401BHEP A61K 8/98 20060101ALI20220401BHEP A61K 31/7088 20060101ALI20220401BHEP A61K 31/713 20060101ALI20220401BHEP A61K 38/00 20060101ALI20220401BHEP A61K 39/00 20060101ALI20220401BHEP A61K 9/127 20060101ALI20220401BHEP A61K 9/51 20060101ALI20220401BHEP A61K 35/16 20150101ALI20220401BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.